Alexander R Moschen
Overview
Explore the profile of Alexander R Moschen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
8092
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pimingstorfer P, Gregus M, Ziachehabi A, Fugger R, Moschen A, Schofl R
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518733
: Endoscopic Submucosal Dissection (ESD) has become the standard therapy for early malignant lesions in the gastrointestinal tract and has shown as good oncological surgery results. Approximately 30% of ESDs...
2.
Watschinger C, Stampfel G, Zollner A, Hoog A, Rossler A, Reiter S, et al.
Viruses
. 2024 Jan;
16(1).
PMID: 38275936
(1) Background: Vulnerable populations including transplant recipients are jeopardised by COVID-19. Herein, we report on B and T cell responses among liver and kidney organ recipients at our centre. (2)...
3.
Effenberger M, Waschina S, Bronowski C, Sturm G, Tassiello O, Sommer F, et al.
Hepatol Commun
. 2023 Jun;
7(7).
PMID: 37314752
Background: HCC is the leading cause of cancer in chronic liver disease. A growing body of experimental mouse models supports the notion that gut-resident and liver-resident microbes control hepatic immune...
4.
Reider S, Watschinger C, Langle J, Pachmann U, Przysiecki N, Pfister A, et al.
J Pers Med
. 2022 Sep;
12(9).
PMID: 36143265
(1) Background: The intestinal microbiome has emerged as a central factor in human physiology and its alteration has been associated with disease. Therefore, great hopes are placed in microbiota-modulating strategies....
5.
Vomstein K, Reider S, Bottcher B, Watschinger C, Kyvelidou C, Tilg H, et al.
J Reprod Immunol
. 2022 May;
151:103634.
PMID: 35550495
In contrast to the former notion of a sterile womb, sequencing techniques have proven a bacterial colonization of the uterus. However, timing of microbiota analysis regarding possible intra-cycle variations as...
6.
Cheon J, Paridaens K, Al Awadhi S, Begun J, Fullarton J, Louis E, et al.
Intest Res
. 2022 Apr;
21(1):161-167.
PMID: 35421913
No abstract available.
7.
Moschen A, Sammy Y, Marjenberg Z, Heptinstall A, Pooley N, Marczewska A
Curr Oncol Rep
. 2022 Mar;
24(7):861-874.
PMID: 35325401
Purpose Of Review: This review aims to summarize and discuss the diverse causes of two major gastrointestinal dysfunction symptoms, diarrhea and constipation, in cancer patients. We also discuss short- and...
8.
Karbiener M, Farcet M, Zollner A, Masuda T, Mori M, Moschen A, et al.
NPJ Vaccines
. 2022 Feb;
7(1):22.
PMID: 35181655
SARS-CoV-2 neutralizing antibodies have been suggested to reflect the efficacy of COVID-19 vaccines. This study reports the direct comparison of the SARS-CoV-2 neutralizing antibody response elicited by a protein- (NVX-CoV2373),...
9.
Watschinger C, Moschen A
Cancer Cell
. 2022 Feb;
40(2):125-127.
PMID: 35167822
In this issue of Cancer Cell, Bell et al. identify the commensal bacterium Lactobacillus reuteri and its major metabolite reuterin as an important gatekeeper and promising target in colorectal cancerogenesis....
10.
Louis E, Paridaens K, Al Awadhi S, Begun J, Cheon J, Dignass A, et al.
BMJ Open Gastroenterol
. 2022 Feb;
9(1).
PMID: 35165124
Objectives: 5-aminosalicylate (mesalazine; 5-ASA) is an established first-line treatment for mild-to-moderate ulcerative colitis (UC). This study aimed to model the benefits of optimising 5-ASA therapy. Methods: A decision tree model...